Damien L Conover from 1920 W Wellington Ave, Chicago, IL 60657, age 48

Resumes

Director

View page

Location:

Chicago, IL

Industry:

Investment Management

Work:

Raymond James Oct 2006 - Jul 2007
Analyst
Morningstar Oct 2006 - Jul 2007
Director
Clearwater Asset Management Apr 2005 - Sep 2006
Analyst
Bmo Financial Group Nov 2001 - Apr 2005
Analyst

Education:

University of Wisconsin - Madison 1999 - 2001
Masters, Finance University of Wisconsin - Madison 1994 - 1999
Bachelors, Finance

Languages:

English

Certifications:

Cfa

Analyst

View page

Location:

Chicago, IL

Industry:

Financial Services

Work:

Morningstar
Analyst

Skills:

Real Estate
Research
Services
Energy
Financial Services
Equity Research

News

1 High-Yield Blue Chip Set To Soar And 1 You Should Ignore

View page

Each DCF fair value is based on a 10+ year growth model with assumptions that are educated guesstimates and change as data comes in. In this case Morningstar agrees that Gilead is undervalued but Damien Conover is more bearish than I am in terms of his growth expectations. On AbbVie we disagree ent

Date

Jun 21, 2018

Category:

Headlines

Source:

Google

Hillary Clinton Announces Plan To Address 'Unjustified' Price Hikes On Life-Saving Drugs

View page

Even though her plan would likely affect a small number of companies, it could be difficult to get Republican lawmakers on board, Morningstar analyst Damien Conover said, adding that a Republican Congress would push back hard on this.

Date

Sep 02, 2016

Category:

Business

Source:

Google

Which stock to buy now, Pfizer or Allergan?

View page

Treasury's new ruling for tax inversions "doesn't change our $38 (a share) Pfizer fair value estimate," and the breakup fee of $400 million Pfizer will pay Allergan for terminating the $160 billion merger "should not affect Pfizer's valuation," said Damien Conover, director of health care equity res

Date

Apr 12, 2016

Category:

Business

Source:

Google

Pfizer Pulls $160B Merger After White House Introduces New Tax Rules

View page

planned to make a decision by 2016 whether to split off its hundreds of generic medicines, but delayed the decision until 2019 after announcing its merger with Allergan. Morningstar analyst Damien Conover had said the decision could be moved to late 2017 or 2018 if the deal with Allergan collapsed.

Date

Apr 06, 2016

Source:

Google

Celltrion, Pfizer win landmark FDA OK for a biosimilar of J&J's blockbuster Remicade

View page

Gorsky is right in predicting that patients won't suddenly switch to an alternative. J&J has $4.5 billion in annual sales riding on that assumption.Morningstar analyst Damien Conover has already noted that Remsima and another Remicade knockoff could grab half of J&J's U.S. revenue by 2020.

Date

Apr 05, 2016

Category:

Health

Source:

Google

Should JNJ, AbbVie and Amgen Feel Threatened by Remicade Biosimilar?

View page

According to Morningstar analyst Damien Conover, Remsima and another Remicade knockoff can be expected to enter the US market by 2018, upon which sales of the branded drug could fall to half of their current levels by as early as 2020.

Date

Feb 10, 2016

Category:

Health

Source:

Google

Executives to lead Valeant as CEO takes medical leave

View page

It is an inopportune time for their leader to take sick leave after the company has faced credibility issues in recent months, said Morningstar analyst Damien Conover. If the company was on solid footing, it wouldnt be as much of an issue.

Date

Dec 28, 2015

Category:

Business

Source:

Google

Merck Jumps, United Therapeutics Drops On Q1 Earnings MRK UTHR

View page

"We believe the market underappreciates Merck's immuno-oncology drug Keytruda," Morningstar analyst Damien Conover wrote in a research note Tuesday. "We expect the addition of the lung cancer indication later in 2015 to bring an additional $5 billion in Keytruda sales at peak."

Date

Apr 28, 2015

Category:

Business

Source:

Google

Videos & Images

Youtube

Finding Economic Moats with Morningstars Erin Lash...

Ed meets with Morningstar's Erin Lash and Damien Conover who offer the...

Duration:

35m 44s

Walking Man by Damien Conover

Duration:

Steam is making me do this for fake internet point...

Le meme.

Duration:

More settlements will appear over time in connecti...

Damien Conover of Morningstar joins CNBC's "Closing Bell" to discuss P...

Duration:

2m 40s

Healthcare Sector: Impact Of Inflation & Geopolitics

Also, Damien Conover believes that the recent healthcare outperformanc...

Duration:

10m 43s

Investing Insights: Dividend Stock and ESG Fund Pi...

... Russ Kinnel shares Morningstar's favorite ESG funds, Damien Conove...

Duration:

14m 33s

Innovation & Resilience Of Biopharma Stocks

... which lends stability regardless of potential recessionary pressur...

Duration:

7m 26s

Are the Dividends of Biopharma Stocks at Risk?

... Damien Conover Healthcare's Defensive Nature Helps Against...

Duration:

7m 21s

Damien L Conover

Damien Conover Phones & Addresses

Resumes

Resumes

Director

Analyst